Zhen Zhang focuses on developing microfluidic and nanotechnology-based platforms for liquid biopsy diagnostics.

Dr. Zhen Zhang is a Postdoctoral Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland. Her research combines nanotechnology, microfluidics, and analytical chemistry to develop advanced liquid biopsy platforms for the non-invasive diagnosis and monitoring of cancer and brain diseases. Zhen applies Surface-Enhanced Raman Spectroscopy (SERS) and molecular profiling to enable real-time disease tracking and improve precision diagnostics.

Currently in the Trau Group.